Skip to main content
. Author manuscript; available in PMC: 2023 Feb 20.
Published in final edited form as: Clin Cancer Res. 2022 Jun 13;28(12):2567–2578. doi: 10.1158/1078-0432.CCR-21-4064

Table 3.

Immune Cell Subsets By Cohort and Stratified by Baseline Dexamethasone (Dex) Use

Cohort A B/B2/B3
Baseline Dex Yes No P value Yes No P value
               
Lymphocyte Subset              
CD3+ # Patients 11 21   39 50  
  Median 1004 1240 NS 523 696 0.0178
CD4+ # Patients 11 21   39 50  
  Median 762 910 NS 323 417 0.01404
CD8+ # Patients 11 21   39 50  
  Median 344 336 NS 192 238 NS
CD4+ Central Memory # Patients 9 20   36 45  
  Median 197 291 NS 152 199 0.0465
CD4+ Effector Memory # Patients 9 20   36 45  
  Median 72 61 NS 39 43 NS
CD4+ Naïve # Patients 9 20   36 45  
  Median 281 440 NS 102 103 NS
CD4+CD38+ # Patients 9 20   36 45  
  Median 459 703 NS 211 273 0.0235
CD4+HLADR+ # Patients 9 20   35 45  
  Median 73 85 NS 53 68 0.0130
CD4+ICOS+ # Patients 9 20   35 45  
  Median 209 324 0.0477 131 212 0.0015
CD8+ Central Memory # Patients 9 20   36 45  
  Median 27 32 NS 21 28 NS
CD8+ Effector Memory # Patients 9 20   36 45  
  Median 33 43 NS 33 35 NS
CD8+ Naive # Patients 9 20   36 45  
  Median 96 125 NS 49 73 NS
CD8+ CD38+ # Patients 9 20   35 45  
  Median 168 243 NS 129 154 NS
CD8+ HLADR+ # Patients 9 20   35 45  
  Median 152 97 NS 81 105 NS
CD8+ ICOS+ # Patients 9 20   35 45  
  Median 35 41 NS 35 48 0.0151
CD4+ Ki67+ # Patients 8 19   35 43  
  Median 13 24 0.0407 8 12 0.0147
CD8+Ki67+ # Patients 8 18   35 42  
  Median 7 6 NS 5 7 NS
Day 15 CD4+Ki67+ # Patients 7 14   24 36  
  Median Neg 31 Neg 12 NS 24 23 NS
Day 15 CD8+Ki67+ # Patients 7 13   22 33  
  Median Neg 7 17 NS 0 33 0.0703

Abbreviations: Dex, dexamethasone; Neg, negative; NS not significant